Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 76-100 of 753 matching filings.

Per page
25
Current page
4
10-K/A File 001-15697

10-K/A filing

Filing date
31 Jul 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
10-K File 001-15697

10-K filing

Filing date
29 Jun 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jun 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-15697

10-Q filing

Filing date
14 Feb 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-Q File 001-15697

10-Q filing

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Nov 2022
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
13 Sep 2022
Reporting date
06 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Aug 2022
Reporting date
28 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Aug 2022
Reporting date
28 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Aug 2022
Reporting date
28 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .